Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
得意分野
Suggested News & Insights
Bay Area General Counsel RoundtableThursday, September 24, 2026SEC Proposes to Rescind Investment Adviser Pay-to-Play RuleSeptember 10, 2026Planning for the Impact of FinCEN’s Corporate Transparency Act RollbackSeptember 9, 2026Permission to Speak (and a Reason To): FinCEN and Banking Agencies Clarify SAR Confidentiality Rules for Customer Communications About Fraud and Account ClosuresSeptember 8, 2026The Evolving Regulatory Landscape for Private Credit: Key Considerations for LendersSeptember 4, 2026Personalized Pricing: The FTC's Newest Enforcement PrioritySeptember 3, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory